Real-time enrollment status for this hematologic malignancies clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT03557619 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Malignancies |
| Phase | Clinical Trial |
| Target Enrollment | 12 participants |
| Active Locations | 3 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 29, 2024 (Aug 29, 2024) |
As of July 13, 2026: Clinical trial NCT03557619 is currently recruiting participants. This clinical trial study for hematologic malignancies is actively seeking new participants at 3 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03557619 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03557619 was last updated Aug 29, 2024 (August 29, 2024). HelloStudys verifies this status automatically.